Simultaneous Estimation of Metoprolol and Telmisartan in Combined Tablet Dosage Form by Using RP-HPLC and UV Spectrophotometry
DOI:
https://doi.org/10.22270/ajprd.v10i4.1153Keywords:
Metoprolol, Telmisartan, RP-HPLC, UV-Visible Detector; ICH Validation.Abstract
An accurate, precise and reproducible RP-HPLC and UV Spectrophotometric method was developed and validated for the simultaneous estimation of Metoprolol and Telmisartan in tablet dosage form. The chromatographic separation was carried out on X-tera C8 column (100mm*4.6mm*5µ), by using the mobile phase (0.05M Sodium phosphate buffer pH 2.8 and methanol) in the ratio 35:65, at a flow rate 1.2ml/min. The detection was carried out at a wave length of 226nm. The retention time for Metoprolol and Telmisartan was found to be 2.338 and 5.559 respectively. UV method involves solving simultaneous equations based on measurement of absorbance at two wavelengths 223nm and 296nm λmax of Metoprolol and Telmisartan respectively. Beer’s law was obeyed in the concentration range of 1.25-6.25μg/ml and 2-10μg/ml for Metoprolol and Telmisartan respectively. The developed methods were validated according to ICH guidelines.
Downloads
References
2. Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arteriosclerosis, thrombosis, and vascular biology. 2010; 30(3):376-381.
3. International Agency for Research on Cancer. Epichlorohydrin. IARC Summary & Evaluation, No. 71. http://www. inchem. org/documents/iarc/vol71/020-epichlorohydrin. html. 1999; 603 Guideline, ICH Harmonized Tripartite.
4. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic RISK M7. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH): Geneva. 2014.
5. Snodin DJ, McCrossen SD. Guidelines and pharmacopoeial standards for pharmaceutical impurities: overview and critical assessment. Regulatory Toxicology and Pharmacology. 2012; 63(2):298-312.
6. Chan CC, Lee YC, Lam H, Zhang XM. Analytical method validation and instrument performance verification. John Wiley & Sons; 2004. p. 23.
7. Guideline ICH. Validation of analytical procedures: text and methodology Q2 (R1). International conference on harmonization, Geneva, Switzerland 2005 Nov (pp. 11-12).
8. Guguloth R, Madhukar A, Umadevi GT: Lalitha and Ravinder A: Analytical Method Development and Validation for the Determination of Metoprolol Succinate in tablet dosage form by RP-HPLC techniques. Journal of Scientific Research in Pharmacy 2016; 5(6):74-77.
9. Ashok P, Narenderan S, Meyyanathan S, Babu B and Vadivelan R: Development and Validation of a RP-HPLC Method for Estimation of Telmisartan in Human Plasma. International Journal of Applied Pharmaceutics 2019; 11(1):237-40.
10. Ruhina T and Mamatha T: A Novel RP HPLC Method for Developmentand Validation of Clinidipine in Bulk and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Technology & Innovation 2017; 5(14):72 -81.
11. Suthakaran R, Bikshapathi D, Shankar C, Prem Kumar B and Ghouse S: A Validated RP-HPLC Method for Estimation of Telmisartan and Metoprolol in its Bulk Form. International Journal of Biomedical Investigation 2018; 1(2):1-13.
12. Prasad KC, Krishna MR, Babu DJ, Kumar NA and Babu GR: Stability indicating Simultaneous Estimation of Metoprolol and Clinidipine by using RP-HPLC. World Journal of Pharmacy and Pharmaceutical Sciences 2017; 6(1):1395-03.
13. Nagaraju K and Chowdary YA: Simultaneous Estimation of Telmisartan and Clinidipine in Combined Tablet Dosage Form by RP-HPLC. International Journal of Engineering Science Invention 2018; 18:39-42.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).